1.
A bacterial cell to cell signal in the lungs of cystic fibrosis patients
by Collier, David N
FEMS microbiology letters, 2002, Vol.215 (1), p.41-46

2.
Pfiesteria complex organisms and human illness
by COLLIER, David N
Southern medical journal (Birmingham, Ala.), 2002, Vol.95 (7), p.720-726

3.
Large recurrent microdeletions associated with schizophrenia
by Stefansson, Hreinn
Nature, 2008, Vol.455 (7210), p.232-236

4.
Common variants conferring risk of schizophrenia
by Stefansson, Hreinn
Nature (London), 2009, Vol.460 (7256), p.744-747

5.
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wi...
by Reilly, Muredach P, Dr
The Lancet (British edition), 2011, Vol.377 (9763), p.383-392

6.
Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial
by Shah, PL, Dr
The Lancet (British edition), 2011, Vol.378 (9795), p.997-1005

7.
Ethnic Differences in Blood Pressure Response to First and Second-Line Antihypertensive Therapies in Patients Randomized in the ASCOT Trial
by Gupta, Ajay K.
American journal of hypertension, 2010-09, Vol.23 (9), p.1023-1030

8.
Virologic and immunologic response to HAART, by age and regimen class
by ALTHOFF, Keri N
AIDS (London), 2010, Vol.24 (16), p.2469-2479

9.
Association between 5-HT2A gene promoter polymorphism and anorexia nervosa
by COLLIER, D. A
The Lancet (British edition), 1997, Vol.350 (9075), p.412-412

10.
Measuring Forearm Blood Flow and Interpreting the Responses to Drugs and Mediators
by Benjamin, Nigel
Hypertension (Dallas, Tex. 1979), 1995-05, Vol.25 (5), p.918-923

11.
Development of a provisional core set of response measures for clinical trials of systemic sclerosis
by Khanna, D
Annals of the Rheumatic Diseases, 2008-05, Vol.67 (5), p.703-70
